NCT03971825View on ClinicalTrials.gov

A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

PHASE1TerminatedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

August 5, 2021

Study Completion Date

August 5, 2021

Conditions
Healthy VolunteersPsoriasis
Interventions
DRUG

CC-92252

CC-92252

OTHER

Placebo

Placebo

Trial Locations (1)

10117

Charite Research Organisation GmbH, Berlin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY